Literature DB >> 7233399

Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin.

C J Carter, J G Kelton, J Hirsh, M Gent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7233399     DOI： 10.1016/0049-3848(84)90045-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.

Authors:  J C Stiekema; H P Wijnand; T G Van Dinther; H C Moelker; J Dawes; A Vinchenzo; H Toeberich
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

2.  ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man.

Authors:  I D Bradbrook; H N Magnani; H C Moelker; P J Morrison; J Robinson; H J Rogers; R G Spector; T Van Dinther; H Wijnand
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

3.  A low molecular weight heparin in hemodialysis.

Authors:  N Maurin; H Kierdorf
Journal:  Klin Wochenschr       Date:  1988-03-15

Review 4.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

5.  Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

Authors:  G F Handeland; U Abildgaard; H A Holm; K E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

7.  [Use of low molecular-weight heparin in hemodialysis patients].

Authors:  J Schrader; J Rieger; H Müschen; W Stibbe; H Köstering; P Kramer; F Scheler
Journal:  Klin Wochenschr       Date:  1985-01-15

Review 8.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

9.  Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study.

Authors:  Y Huet; M Gouault-Heilmann; G Contant; C Brun-Buisson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 10.  Comprehensive Landscape of Heparin Therapy for COVID-19.

Authors:  Chen Shi; Wu Tingting; Jin-Ping Li; Mitchell A Sullivan; Cong Wang; Hanxiang Wang; Bin Deng; Yu Zhang
Journal:  Carbohydr Polym       Date:  2020-10-22       Impact factor: 10.723
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.